AC Immune (ACIU) Cash from Financing Activities (2015 - 2025)
AC Immune (ACIU) reported Cash from Financing Activities of -$326555.3 for Q4 2025, down 45.21% year-over-year from -$596048.2 in Q4 2024, and down 259.28% on a QoQ basis from $205018.0 in Q3 2025.
AC Immune (ACIU) has 11 years of Cash from Financing Activities data on file, last reported at -$326555.3 in Q4 2025.
- Quarterly Cash from Financing Activities fell 45.21% year-over-year to -$326555.3 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$706846.9 (up 85.0% YoY) and the FY2025 annual result came in at -$1.2 million, up 3.77% from the prior year.
- Cash from Financing Activities fell to -$326555.3 in Q4 2025 per ACIU's latest filing, from $205018.0 in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $46.3 million in Q4 2023 and bottomed at -$3.6 million in Q3 2024.
- The 5-year median for Cash from Financing Activities is -$144640.5 (2022), against an average of $4.3 million.
- The widest annual swing landed in 2023, when Cash from Financing Activities jumped 29609.2%; it then tumbled 815.68% in 2024.
- Tracing ACIU's Cash from Financing Activities over 5 years: stood at $31.2 million in 2021, then plunged by 100.5% to -$156741.3 in 2022, then jumped by 29609.2% to $46.3 million in 2023, then slumped by 100.49% to -$224879.8 in 2024, then tumbled by 45.21% to -$326555.3 in 2025.
- Per Business Quant, the three latest ACIU Cash from Financing Activities figures stand at -$326555.3 (Q4 2025), $205018.0 (Q3 2025), and -$298348.9 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -326,555.32 |
| Dec 31, 2025 | -326,555.32 |
| Sep 30, 2025 | 205,017.96 |
| Sep 30, 2025 | 205,017.96 |
| Jun 30, 2025 | -298,348.89 |
| Jun 30, 2025 | -298,348.89 |
| Mar 31, 2025 | -286,960.64 |
| Mar 31, 2025 | -286,960.64 |
| Dec 31, 2024 | -224,879.80 |
| Dec 31, 2024 | -224,879.80 |
| Sep 30, 2024 | -3.63 Mn |
| Sep 30, 2024 | -3.63 Mn |
| Jun 30, 2024 | -68,559.20 |
| Jun 30, 2024 | -68,559.20 |
| Mar 31, 2024 | -788,229.43 |
| Mar 31, 2024 | -788,229.43 |
| Dec 31, 2023 | 46.25 Mn |
| Dec 31, 2023 | 46.25 Mn |
| Sep 30, 2023 | 507,204.35 |
| Sep 30, 2023 | 507,204.35 |
| Jun 30, 2023 | 2.13 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | -152,443.92 |
| Mar 31, 2023 | -152,443.92 |
| Dec 31, 2022 | -156,741.31 |
| Dec 31, 2022 | -156,741.31 |
| Sep 30, 2022 | -147,034.84 |
| Sep 30, 2022 | -147,034.84 |
| Jun 30, 2022 | -142,246.14 |
| Jun 30, 2022 | -142,246.14 |
| Mar 31, 2022 | -991,852.47 |
| Mar 31, 2022 | -991,852.47 |
| Dec 31, 2021 | 31.16 Mn |
| Dec 31, 2021 | 31.16 Mn |
| Sep 30, 2021 | 4.71 Mn |
| Sep 30, 2021 | 4.71 Mn |
| Jun 30, 2021 | -20,836.30 |
| Jun 30, 2021 | -20,836.30 |
| Mar 31, 2021 | 8.52 Mn |
| Mar 31, 2021 | 8.52 Mn |
| Dec 31, 2020 | -508,831.58 |
| Dec 31, 2020 | -508,831.58 |
| Sep 30, 2020 | 149,918.44 |
| Sep 30, 2020 | 149,918.44 |
| Jun 30, 2020 | -111,045.87 |
| Jun 30, 2020 | -111,045.87 |
| Mar 31, 2020 | -386,658.63 |
| Mar 31, 2020 | -386,658.63 |
| Dec 31, 2019 | -8,083.07 |
| Dec 31, 2019 | -8,083.07 |
| Sep 30, 2019 | -109,614.75 |
| Sep 30, 2019 | -109,614.75 |
| Jun 30, 2019 | -514,610.87 |
| Jun 30, 2019 | -514,610.87 |
| Mar 31, 2019 | 50.45 Mn |
| Mar 31, 2019 | 50.45 Mn |
| Dec 31, 2018 | -501,412.56 |
| Dec 31, 2018 | -501,412.56 |
| Sep 30, 2018 | 111.53 Mn |
| Sep 30, 2018 | 111.53 Mn |
| Jun 30, 2018 | 144,265.60 |
| Jun 30, 2018 | 144,265.60 |
| Mar 31, 2018 | 1,054.41 |
| Mar 31, 2018 | 1,054.41 |
| Dec 31, 2017 | -144.67 Mn |
| Dec 31, 2017 | -144.67 Mn |
| Sep 30, 2017 | 148.53 Mn |
| Sep 30, 2017 | 148.53 Mn |
| Jun 30, 2017 | 62,929.92 |
| Jun 30, 2017 | 62,929.92 |
| Mar 31, 2017 | 28,882.94 |
| Mar 31, 2017 | 28,882.94 |
| Dec 31, 2016 | -2.47 Mn |
| Dec 31, 2016 | -2.47 Mn |
| Sep 30, 2016 | 69.81 Mn |
| Sep 30, 2016 | 69.81 Mn |
| Jun 30, 2016 | 13.95 Mn |
| Jun 30, 2016 | 13.95 Mn |
| Mar 31, 2016 | -380,614.90 |
| Mar 31, 2016 | -380,614.90 |
| Dec 31, 2015 | 28.03 Mn |
| Dec 31, 2015 | 28.03 Mn |